Your browser doesn't support javascript.
loading
FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.
Poinas, Alexandra; Lemoigne, Marie; Le Naour, Sarah; Nguyen, Jean-Michel; Schirr-Bonnans, Solène; Riche, Valery-Pierre; Vrignaud, Florence; Machet, Laurent; Claudel, Jean-Paul; Leccia, Marie-Thérèse; Hainaut, Ewa; Beneton, Nathalie; Dert, Cécile; Boisrobert, Aurélie; Flet, Laurent; Chiffoleau, Anne; Corvec, Stéphane; Khammari, Amir; Dréno, Brigitte.
Afiliación
  • Poinas A; Clinical Investigation Centre CIC1413, CHU Nantes and INSERM, Nantes, France. alexandra.poinas@chu-nantes.fr.
  • Lemoigne M; Dermatology Department, CHU Nantes, Nantes University, CRCINA, Nantes, France.
  • Le Naour S; Dermatology Department, CHU Nantes, Nantes University, CRCINA, Nantes, France.
  • Nguyen JM; Department of Epidemiology and Biostatistics, CHU Nantes, Nantes, France.
  • Schirr-Bonnans S; Service Evaluation Economique et Développement des Produits de Santé, Département Partenariats et Innovation, Centre Hospitalier Universitaire de Nantes, Nantes University, Nantes, France.
  • Riche VP; Service Evaluation Economique et Développement des Produits de Santé, Département Partenariats et Innovation, Centre Hospitalier Universitaire de Nantes, Nantes University, Nantes, France.
  • Vrignaud F; Clinical Investigation Centre CIC1413, CHU Nantes and INSERM, Nantes, France.
  • Machet L; Department of Dermatology, CHU Tours, INSERM U1253, University of Tours, Tours, France.
  • Claudel JP; Private Practice, Tours, France.
  • Leccia MT; Department of Dermatology, Allergology and Photobiology, CHU A. Michallon, Grenoble, France.
  • Hainaut E; Service de Dermatologie, Poitiers University Hospital, Poitiers, France.
  • Beneton N; Service de Dermatologie, Le Mans Hospital, Le Mans, France.
  • Dert C; Service Evaluation Economique et Développement des Produits de Santé, Département Partenariats et Innovation, Centre Hospitalier Universitaire de Nantes, Nantes University, Nantes, France.
  • Boisrobert A; Clinical Investigation Centre CIC1413, CHU Nantes and INSERM, Nantes, France.
  • Flet L; Dermatology Department, CHU Nantes, Nantes University, CRCINA, Nantes, France.
  • Chiffoleau A; Department of Pharmacy, CHU Nantes, Nantes, France.
  • Corvec S; Direction de la Recherche, Département Promotion, Cellule Vigilances, Centre Hospitalier Universitaire de Nantes, Nantes, France.
  • Khammari A; CHU Nantes, Service de Bactériologie-Hygiène Hospitalière, CRCINA, INSERM, U1232, Université de Nantes, Nantes, France.
  • Dréno B; Clinical Investigation Centre CIC1413, CHU Nantes and INSERM, Nantes, France.
Trials ; 21(1): 571, 2020 Jun 25.
Article en En | MEDLINE | ID: mdl-32586344
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Espironolactona / Acné Vulgar / Antagonistas de Receptores de Mineralocorticoides Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Female / Humans País/Región como asunto: Europa Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Espironolactona / Acné Vulgar / Antagonistas de Receptores de Mineralocorticoides Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Female / Humans País/Región como asunto: Europa Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2020 Tipo del documento: Article País de afiliación: Francia